Skip to Content

Press Releases

IVI online discussion forum provides answers to Optometry students on Overseas Education

An IVI online discussion session on ‘Optometry Education Overseas’ on 27 May evoked an
enthusiastic response from students.
Some 100 students from across India took part in the panel discussion on Zoom platform. It
was also live streamed on YouTube where it received 560 views. Questions were posed by
participants both on the Zoom platform as well as by those watching YouTube.
“The online discussion was much needed and the panel of four experts provided an
excellent perspective on various aspects of studying abroad to the student participants,”
said IVI’s CEO Vinod Daniel.
“Among others, the discussions focused on identifying the core interest area, finding the
right mentor, preparing for university processes, and benefits of an international exposure.”
“The session also discussed competency of the educational systems and the graduates,
scope of practice and research, as well as support grants and scholarships,” added Mr
The panel provided expert guidance and responses to questions.
The panel consisted of Dr Shrikant R Bharadwaj, Director, Brien Holden Institute of
Optometry & Vision Sciences, and Scientist, Prof Brien Holden Eye Research Centre/LV
Prasad Eye Institute, Hyderabad, Prof Pavan K Verkicharla, Scientist, Myopia Clinic, Prof
Brien Holden Eye Research Centre, Dr Uday Kumar Addepalli, Consultant, Results In Health
and Enablement, Netherlands, and Ms Sandhya Shekar, MS Vision Sciences/Research
Assistant, Visual Performance Institute, Pacific University, Forest Grove, USA. Ms Jissa
James, IVI’s General Manager, Professional Development, moderated the session.
About India Vision Institute (IVI)
India Vision Institute (IVI) is an independent, not-for-profit registered trust established in
2012. It is focused on supporting and promoting eye health awareness, research, education
and technological development in Indian Optometry to advance capacity in vision
correction, and prevention of eye disease and blindness. (
For additional queries, contact Shekhar Nambiar, +919810154167